Mr. Fintan Slye:

I understand the Deputy's point. I have noted in other contributions the need for EirGrid to improve communication of information on the specific details. I will reflect on how we can do this better because it is a good point.

The Deputy asked whether EirGrid was engaging with oncologists to determine the health effects. Dr. Mezei is a medical doctor and a scientist and I ask him to comment on our work in that field and the current scientific thinking.